Nat Lenzo gave a presentation at the NOX AGM two years ago. He...

Nat Lenzo gave a presentation at the NOX AGM two years ago. He is a Theranostics expert who is testing the effectiveness of a range of targeted radionuclides against different forms of cancer; and he believes Veyonda will improve the performance of each of these treatments.

It sounds like Professor Lenzo has been using Veyonda on a compassionate basis for some times. The results must be good, otherwise GenesisCare would not formalise the arrangement.

GenesisCare has treatment centres in Australia and Europe. My guess is that Noxopharm will be paid to supply Veyonda, which would provide ongoing funds for the Company.